02/22/2012 - 10:08am

Novartis plans to pay up to $440 million for rights to a drug for treating hepatitis C made by Enanta Pharmaceuticals, Enanta said.

02/21/2012 - 11:20am

An executive order from the Obama administration has spurred the Food and Drug Administration to address shortages of two cancer drugs and issue draft guidance for the industry to help prevent future shortages, the agency said Tuesday.

02/17/2012 - 6:55pm

The Food and Drug Administration has approved a drug made by Merck for Type 2 diabetes, the drug maker said. Merck announced the approval of Janumet XR (sitagliptin and metformin hydrochloride) extended-release tablets as a once-daily treatment for the disease.

02/17/2012 - 6:55pm

One of the main plotlines of the big story called the drug industry over the past several years has been the patent cliff, the steady loss of patent protection on blockbuster primary care drugs and subsequent generic competition that has forced many drug companies to find new revenue streams.

02/16/2012 - 4:09pm

Fougera Pharmaceuticals has promoted Walt Kaczmarek to serve as the company's SVP commercial operations, the drug maker announced.

02/16/2012 - 2:52pm

The global market for celiac disease is expected to grow substantially over the decade as more people are diagnosed with the condition, according to a new report.

02/15/2012 - 2:51pm

Managed care and prescription plans are working to switch patients to generic versions of Pfizer's Lipitor despite the drug maker's efforts to reduce costs for the branded version, a new study suggested.

02/15/2012 - 10:23am

Mylan is changing the name of its branded specialty pharmaceutical business, the company said Wednesday.

02/14/2012 - 9:51am

Bristol-Myers Squibb has completed its acquisition of a developer of hepatitis C treatments.